BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37829963)

  • 1. Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review.
    Asiri AS; Algarni SS; Althubaiti AQ; Alzubaidi MA; Alghamdi JA; Almalki GA
    Cureus; 2023 Sep; 15(9):e45019. PubMed ID: 37829963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
    Shimizu H; Ebana R; Kudo T; Sato T; Hara T; Hosoi K; Usami M; Yoshida M; Takeuchi I; Nakase H; Iwama I; Arai K; Shimizu T
    J Gastroenterol; 2022 May; 57(5):344-356. PubMed ID: 35165800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease].
    Bonnín Tomàs A; Vila Vidal M; Rosell Camps A
    Rev Esp Enferm Dig; 2007 Dec; 99(12):689-93. PubMed ID: 18290691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study.
    Nakamura S; Imaeda H; Nishikawa H; Iimuro M; Matsuura M; Oka H; Oku J; Miyazaki T; Honda H; Watanabe K; Nakase H; Andoh A
    Intest Res; 2018 Oct; 16(4):554-562. PubMed ID: 30301337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Ma C; Lumb R; Walker EV; Foshaug RR; Dang TT; Verma S; Huang VW; Kroeker KI; Wong K; Dieleman LA; Fedorak RN; Halloran BP
    Inflamm Bowel Dis; 2017 Sep; 23(9):1643-1649. PubMed ID: 28644184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn's disease.
    Somwaru AS; Khanijow V; Katabathina VS
    BMC Gastroenterol; 2019 Dec; 19(1):210. PubMed ID: 31805875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
    Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.
    An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J
    Med J Aust; 2019 Nov; 211(10):461-467. PubMed ID: 31680263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.
    Campbell JP; Zierold C; Rode AM; Blocki FA; Vaughn BP
    J Clin Gastroenterol; 2021 Mar; 55(3):239-243. PubMed ID: 32324678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy].
    García Sánchez Mdel V; González R; Iglesias Flores E; Gómez Camacho F; Casais Juanena L; Cerezo Ruiz A; Montero Pérez-Barquero M; Muntané J; de Dios Vega JF
    Med Clin (Barc); 2006 Jun; 127(2):41-6. PubMed ID: 16801001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin for differentiating between irritable bowel syndrome and inflammatory bowel disease: a useful screen in daily gastroenterology practice.
    Banerjee A; Srinivas M; Eyre R; Ellis R; Waugh N; Bardhan KD; Basumani P
    Frontline Gastroenterol; 2015 Jan; 6(1):20-26. PubMed ID: 28839790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of fecal calprotectin.
    Ricciuto A; Griffiths AM
    Crit Rev Clin Lab Sci; 2019 Aug; 56(5):307-320. PubMed ID: 31088326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fecal calprotectin concentration in the differential diagnosis of bowel diseases].
    Osipenko MF; Livzan MA; Skalinskaya MI; Lyalyukova EA
    Ter Arkh; 2015; 87(2):30-33. PubMed ID: 25864345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis.
    Motwani KK; Alizadeh M; Abutaleb A; Grossman J; Wellington J; Cross RK;
    Dig Dis Sci; 2024 Jun; 69(6):2154-2163. PubMed ID: 38580888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease.
    Colman RJ; Tsai YT; Jackson K; Boyle BM; Noe JD; Hyams JS; D'Haens GRAM; van Limbergen J; Rosen MJ; Denson LA; Minar P
    Inflamm Bowel Dis; 2021 Jun; 27(7):1045-1051. PubMed ID: 32944769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Fecal Calprotectin as a Noninvasive Indicator for Ulcerative Colitis Disease Activity.
    Nakov RV; Nakov VN; Gerova VA; Tankova LT
    Folia Med (Plovdiv); 2019 Jun; 61(2):188-196. PubMed ID: 31301663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.